Author
Listed:
- Robert C. Reid
(Institute for Molecular Bioscience, The University of Queensland)
- Mei-Kwan Yau
(Institute for Molecular Bioscience, The University of Queensland)
- Ranee Singh
(Institute for Molecular Bioscience, The University of Queensland)
- Johan K. Hamidon
(Institute for Molecular Bioscience, The University of Queensland)
- Anthony N. Reed
(Institute for Molecular Bioscience, The University of Queensland)
- Peifei Chu
(Institute for Molecular Bioscience, The University of Queensland)
- Jacky Y. Suen
(Institute for Molecular Bioscience, The University of Queensland)
- Martin J. Stoermer
(Institute for Molecular Bioscience, The University of Queensland)
- Jade S. Blakeney
(Institute for Molecular Bioscience, The University of Queensland)
- Junxian Lim
(Institute for Molecular Bioscience, The University of Queensland)
- Jonathan M. Faber
(Institute for Molecular Bioscience, The University of Queensland)
- David P. Fairlie
(Institute for Molecular Bioscience, The University of Queensland)
Abstract
A significant challenge in chemistry is to rationally reproduce the functional potency of a protein in a small molecule, which is cheaper to manufacture, non-immunogenic, and also both stable and bioavailable. Synthetic peptides corresponding to small bioactive protein surfaces do not form stable structures in water and do not exhibit the functional potencies of proteins. Here we describe a novel approach to growing small molecules with protein-like potencies from a functionally important amino acid of a protein. A 77-residue human inflammatory protein (complement C3a) important in innate immunity is rationally transformed to equipotent small molecules, using peptide surrogates that incorporate a turn-inducing heterocycle with correctly positioned hydrogen-bond-accepting atoms. Small molecule agonists (molecular weight
Suggested Citation
Robert C. Reid & Mei-Kwan Yau & Ranee Singh & Johan K. Hamidon & Anthony N. Reed & Peifei Chu & Jacky Y. Suen & Martin J. Stoermer & Jade S. Blakeney & Junxian Lim & Jonathan M. Faber & David P. Fairl, 2013.
"Downsizing a human inflammatory protein to a small molecule with equal potency and functionality,"
Nature Communications, Nature, vol. 4(1), pages 1-9, November.
Handle:
RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms3802
DOI: 10.1038/ncomms3802
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms3802. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.